Incidence and features of heparin-induced thrombocytopenia (HIT) in burn patients: A retrospective study

Thrombosis and Haemostasis

Volumn 99, Issue 5, 2008, Pages 974-976

  Hejl, Carine Garcia ^a   Leclerc, Thomas ^a   Bargues, Laurent ^a   Samson, Thierry ^a   Foissaud, Vincent ^a  

^a PERCY MILITARY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DANAPAROID; HEPARIN; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN;

ADOLESCENT; ADULT; BURN PATIENT; CONTROLLED STUDY; DISEASE SEVERITY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; LETTER; MAJOR CLINICAL STUDY; MORBIDITY; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOEMBOLISM;

ADOLESCENT; ADULT; ANTICOAGULANTS; AUTOANTIBODIES; BURNS; HEPARIN; HUMANS; INCIDENCE; MIDDLE AGED; PLATELET COUNT; PLATELET FACTOR 4; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; THROMBOCYTOPENIA; THROMBOEMBOLISM;

EID: 43949118075     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-10-0625     Document Type: Letter

References (14)

1. Warkentin TE. New approaches to the diagnosis of heparin-induced thrombocytopenia. Chest 2005; 127: 35S-45S.
2. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 311S-337S.
3. Spinler SA. New concepts in Heparin-induced thrombocytopenia: diagnosis and management. J Thromb Thrombolysis 2006; 21: 17-21.
4. Société française d'anesthésie reanimation. Conférence d'experts. Thrombopénie induite par l'héparine. Ann Fr Anesth Reanim 2003; 22: 150-159.
5. Lobo B, Finch C, Howard A, Minhas S. Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia. Thromb Haemost 2008; 99: 208-214.
6. Warkentin TE. Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT) - bridging the River Coumarin. Thromb Haemost 2008; 99: 2-3.
7. Gueugniaud PY, Carsin H, Bertin-Maghit M, et al. Current advances in the initial management of major thermal burns. Intensive Care Med 2000; 26: 848-856.
8. Société Française d'Anesthésie et de Réanimation - Agence Nationale d'Accréditation et d'Evaluation en Santé. Recommandations pour la pratique clinique (RPC). Prévention de la maladie thromboembolique veineuse péri-opératoire et obstétricale (Groupe Brûlés et chirurgie plastique). Ann Fr Anesth Reanim 2005; 24: 853-861.
9. Horner BM, Myers SR. Don't miss HIT (heparin induced thrombocytopenia). Burns 2004; 30: 88-90.
10. Bargues L, Foissaud V, Jault P, et al. Heparin-induced thrombocytopenia: report of four cases in severely burned patients. Ann Fr Anesth Reanim 2006; 25: 1135-1139.
11. Scott JR, Klein MB, Gernsheimer T, et al. Arterial and venous complications of heparin-induced thrombocytopenia in burn patients. J Burn Care Res 2007; 28: 71-75.
12. Everett BM, Yeh R, Foo SY, et al. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery. Ann Thorac Surg 2007; 83: 592-597.
13. Girolami B, Girolami A. Heparin-induced thrombocytopenia: a review. Semin Thromb Haemost 2006; 32: 803-809.
14. Davidson SJ, Wadham P, Rogers L, et al. Endothelial cell damage in heparin-induced thrombocytopenia. Blood Coagul Fibrinolysis 2007; 18: 317-320.